Huaier granules to lower breast cancer tumor markers after surgery
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether Huaier granules can reduce blood “tumor marker” levels in people with breast cancer after surgery. If your marker levels are high but scans show no spread, the study may help see if the granules can keep markers from staying elevated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 (any gender).
- You’ve had surgery for breast cancer and pathology confirmed it.
- Recent scans and/or biopsy show no return (recurrence) and no spread (metastasis).
- At least one tumor marker (CEA, CA125, or CA153) is above the normal range.
- Your recent blood tests are in a safe range (liver: AST/ALT < 3× normal; bilirubin ≤ 2× normal; kidney: creatinine < 1.5× normal; blood counts: Hb ≥ 9, platelets ≥ 60, neutrophils > 1).
- You can take medicine by mouth, are not pregnant or breastfeeding, and don’t have an allergy to Huaier granules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.
This trial tests a new drug, QL1706, given alongside chemotherapy before surgery for a certain type of breast cancer. It aims to see if this combination helps shrink tumors before they are removed.
This trial tests if Huaier Granule, a traditional Chinese medicine, can reduce protein in the urine of breast cancer patients. It is for women who have proteinuria after immunotherapy or anti-angiogenic therapy.
This trial studies whether Huaier granules can slow or control advanced breast cancer that has not spread to internal organs (like the liver or lungs). It may help people who have limited treatment options, especially when standard stronger local treatments (surgery or radiation) aren’t being used.
This trial tests whether a Chinese herbal medicine called Huaier granules works better than standard chemotherapy for people with pancreatic cancer that was removed by surgery. Participants can choose to take Huaier granules or standard chemotherapy, and researchers will compare outcomes.
This trial looks at whether adding Huaier granules to usual after-surgery treatment can improve outcomes for people with high-risk early-stage triple-negative breast cancer. It focuses on whether the added supplement is safe and helpful after standard care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.